Tuesday, 07 Apr 2020


Datesort ascending Type Title Save
13 Feb 2020 Social RT @uptoTate: Do you believe nrAxSpA exists? #RWCS2020 @RheumNow @RWCSmtg
13 Feb 2020 Social RT @Janetbirdope: Do you load secukinumab in SpA? #RWCS2020 @RheumNow
13 Feb 2020 Social 1st Jan inhibitor in AS - upadacitinib, it works! Drs Ruderman/Kavanaugh #RWCS2020 @RWCSmtg https://t.co/KLJh43h7pz
13 Feb 2020 Social RT @Janetbirdope: Irritable bowel disease seems increased in axial SpA and the surprise is that is is more frequent in those with higher di…
13 Feb 2020 Social RT @Janetbirdope: Non radiographic ankylosing spondylitis pts are younger, less % males and lower CRP than radiographic AS #RWCS2020 @Rhe…
10 Feb 2020 News Bimekizumab Effective in Active Psoriatic Arthritis
08 Feb 2020 Social The RheumNow Podcast is up! SF crystals, Stills biomarkers, best drugs for Psoriasis, Head drop, urticaria and FDG-PET vs MRA. Watch it here https://t.co/5unF73Ir08 or join the 15,000 podcasters who listen every month on iTunes or here https://t.co/kIjK124W7s
07 Feb 2020 News Upadacitinib Effective in Phase 3 Psoriatic Arthritis Study
05 Feb 2020 News Which Biologics are Best in Psoriasis
29 Jan 2020 ACR Video QD Clinic - Inflammatory Hips
24 Jan 2020 Social The RheumNow Podcast is up! This week: what happens before PsA; DASH diet and urate; and are RA patient reported Flares valid? Check out the videocast https://t.co/JDbYOiMYvU or listen to the podcast on iTunes or SoundCloud https://t.co/nK6l6z39fR
23 Jan 2020 Social Health Care Utilization prior to the Dx of Psoriatic Arthritis #PsA is significantly 2 fold higher. Study of 462 PsA & 2310 comparators shows more visits to PCP for MSK issues in 1-5 yrs prior, as well as use of other MSK specialists in 5 yrs preceding Dx. https://t.co/5729ya9Ahr
22 Jan 2020 Social IL-37 may be a target for psoriasis. IL-37 is downregulated in lesional skin & IL-37 serum levels correlate with psoriasis severity. IL-37 is an anti-inflammatory & immunosuppressive cytokine from IL-1 family. Tofacitinib may increase IL-37 in psoriasis https://t.co/jPaGlcDFV2
08 Jan 2020 Social Systematic literature of biologic Rx of dactylitis & enthesitis in Psoriatic arthritis. 18 trials, 6981 patients showed that TNF inhib & ustekinumab, secukinumab, ixekizumab were 2-3 fold significantly better than PBO at resolution of dactylitis by Wk 24. https://t.co/HlQcw5cXsN
06 Jan 2020 News Taltz Shines in Non-Radiographic Axial Spondyloarthritis
27 Dec 2019 News Best of 2019 - SEAM-PsA Study - Does Monotherapy MTX Win Despite Losing to Etanercept in Psoriatic Arthritis?
26 Dec 2019 News Best of 2019 - ACR/SPARTAN Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
20 Dec 2019 Social COAST-X trial: Ixekizumab was superior to placebo for improving signs and symptoms in patients with non-radiographic axial spondyloarthritis at weeks 16 and 52. ASAS40 at week 52 IXE q4W 30% vs. IXE Q2W 31% vs PBO 13%, p=0·0037 https://t.co/GrQnakvor1
20 Dec 2019 News Upadacitinib Effective in Ankylosing Spondylitis
17 Dec 2019 Social Should AS/SpA pts have ECHO for AI/AR? I say YES; Swedish study of 6448 AS pts shows 2 fold higher risk AI https://t.co/lchlsGXAJi. Another ECHO study 187 AS pts shows an incr prevalence (18%) of AI murmur esp w/ longstanding disease or age >50 (>50%) https://t.co/Np21FwCbBP